News
When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...
10h
SurvivorNet on MSNThe DESTINY Trial: New Drug Combo Can Keep HER2-Positive Metastatic Breast Cancer Under Control For LongerPositive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...
16h
MedPage Today on MSNADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast CancerAs such, "the combination of T-DXd and pertuzumab may represent a new first-line standard of care for patients with ...
Stephanie Walker was diagnosed with metastatic breast cancer (MBC) nearly a decade ago — an experience she says transformed ...
Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...
Daniel J. Stone Former President Joe Biden’s metastatic cancer diagnosis brings together two controversial issues: PSA testing for prostate cancer and presidential politics. To understand what is at ...
3hon MSN
Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...
3h
News-Medical.Net on MSNNew fluorescent tool tracks cancer cell movement in real timeCancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...
AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations.
Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results